Ralfinamide mesylate( FCE-26742A (mesylate) )

Catalog No. M20790 CAS No. 202825-45-4

Ralfinamide mesylate is an orally available Na+ channel blocker.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	181	In Stock
5MG	115	In Stock
10MG	180	In Stock
25MG	296	In Stock
50MG	384	In Stock
100MG	542	In Stock
200MG	728	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Ralfinamide mesylate
Note

Research use only, not for human use.
Brief Description

Ralfinamide mesylate is an orally available Na+ channel blocker.
Description

Ralfinamide mesylate is an orally available Na+ channel blocker.
In Vitro

——
In Vivo

Ralfinamide (30 mg/kg, 60 mg/kg; p.o.; twice daily; 42 days) treated with Ralfinamide (80 mg/kg; p.o.; twice daily; 7 days) preoperatively suppresses neuropathic pain. Animal Model:81 adult male Sprague–Dawley male rats (260–460 g) Dosage:80 mg/kg (7 days preoperatively), 30 mg/kg, 60 mg/kg (postoperative)Administration:Oral gavage; twice daily; until postoperative day 42 Result:Suppressed neuropathic pain.
Synonyms

FCE-26742A (mesylate)
Pathway

Membrane Transporter/Ion Channel
Target

Sodium Channel
Recptor

Sodium Channel
Research Area

——
Indication

——

Chemical Information

CAS Number

202825-45-4
Formula Weight

398.45
Molecular Formula

C18H23FN2O5S?
Purity

>98% (HPLC)
Solubility

——
SMILES

CC(NCc1ccc(OCc2ccccc2F)cc1)C(N)=O.CS(=O)(=O)O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Liang X Yu G Su R . Effects of ralfinamide in models of nerve injury and chemotherapy-induced neuropathic pain[J]. European journal of pharmacology 2018 823:27-34.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks